Links

Tools

Export citation

Search in Google Scholar

A phenotypic resistance assay for clinical HCV isolates could help rationalise DAA therapy in individuals experiencing recurrent virologic failure

Proceedings article published in 2019 by Christopher Jones ORCID, Ana Maria Ortega-Prieto, Graham Cooke, Marcus Dorner
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown